2009. Evaluation of Risk Markers Fluctuation During an Initial Therapy with Rosiglitazon in Patients Suffering from Metabolic Syndrome. Biomolecules and Biomedicine. 9, 4 (Nov. 2009), 320–328. DOI:https://doi.org/10.17305/bjbms.2009.2788.